Literature DB >> 19097889

Development of pH-responsive core-shell nanocarriers for delivery of therapeutic and diagnostic agents.

Shangjie Xu1, Ying Luo, Ralph Graeser, André Warnecke, Felix Kratz, Peter Hauff, Kai Licha, Rainer Haag.   

Abstract

In this paper new dendritic core-shell architectures with pH-labile linkers based on hyperbranched polyglycerol cores and biocompatible poly(ethylene glycol) shells were synthesized which encapsulate the anticancer agent doxorubicin and a dye for near-infrared imaging, an indotricarbocyanine. Acid-sensitive properties of the new nanocarriers and in vitro cytotoxicity of the doxorubicin-nanocarrier are presented as well as preliminary data regarding their toxicity and tumor targeting potential in nude mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19097889     DOI: 10.1016/j.bmcl.2008.01.043

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Multifunctional nanomedicines: potentials and prospects.

Authors:  Udita Agrawal; Madhu Gupta; Rajesh S Jadon; Rajeev Sharma; S P Vyas
Journal:  Drug Deliv Transl Res       Date:  2013-10       Impact factor: 4.617

2.  Polyvalent saccharide-functionalized generation 3 poly(amidoamine) dendrimer-methotrexate conjugate as a potential anticancer agent.

Authors:  Yuehua Zhang; Thommey P Thomas; Kyung-Hoon Lee; Minghsin Li; Hong Zong; Ankur M Desai; Alina Kotlyar; Baohua Huang; Mark M Banaszak Holl; James R Baker
Journal:  Bioorg Med Chem       Date:  2011-03-12       Impact factor: 3.641

3.  Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes.

Authors:  Yogita Patil-Sen; Amin Sadeghpour; Michael Rappolt; Chandrashekhar V Kulkarni
Journal:  J Vis Exp       Date:  2016-02-19       Impact factor: 1.355

4.  New side chain design for pH-responsive block copolymers for drug delivery.

Authors:  Priyanka Ray; Narendra Kale; Mohiuddin Quadir
Journal:  Colloids Surf B Biointerfaces       Date:  2021-01-06       Impact factor: 5.999

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.